Financial statements Mako Pharma

Balance sheet of Mako Pharma

Company age:
Age:
12 y. 8 m. 12 d.
Share capital:
Share capital:
100 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of MAKO PHARMA

Year
2018
2019
2020
2021
2022
2023
Total assets 5 558 539,99 6 900 502,60 8 866 150,98 10 320 631,23 13 096 960,21 17 427 049,45
A. Fixed assets 1 265 066,85 1 425 119,71 1 767 004,35 1 437 066,47 921 258,71 5 934 625,25
B. Current assets 4 293 473,14 5 475 382,89 7 099 146,63 8 883 564,76 12 175 701,50 11 492 424,20
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 5 558 539,99 6 900 502,60 8 866 150,98 10 320 631,23 13 096 960,21 17 427 049,45
A. Equity 4 651 541,17 5 835 011,15 7 738 040,89 8 873 402,69 11 386 716,44 12 636 310,83
B. Liabilities and provisions for liabilities 906 998,82 1 065 491,45 1 128 110,09 1 447 228,54 1 710 243,77 4 790 738,62
I. Long-term liabilities 0,00 0,00 421 065,00 62 031,87 62 031,87 3 500 000,00
II. Short-term liabilities 517 238,93 916 689,04 558 242,68 1 190 097,96 1 499 409,49 1 129 136,21
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.